OpenAlex
PricingAboutJobs
Log inGet started
Work

Cardiovascular events in patients receiving immuno-oncology agents, in phase I clinical trials: CAVIO study.

HTML

Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2024.42.16_suppl.e24009
Authors: Paola Zagami, Eleonora Nicolò, Dario Trapani, Luca Boscolo Bielo, Carmine Valenza, Ambra Carnevale Schianca, Gloria Pellizzari, Grazia Castellano, Sara Gandini, Silvano Vignati, Maria Angela Massaro, Chiara Busacca, Antonio Marra, Beatrice Taurelli Salimbeni, Carmen Belli, Ida Minchella, Marzia Adelia Locatelli, Angela Esposito, Carmen Criscitiello, Giuseppe Curigliano
Institutions: University of Milan, European Institute of Oncology, Weill Cornell Medicine
Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cardiovascular events, immune checkpoint inhibitors, hypertension, thrombosis, myocarditis, anticoagulant use, overall survival, progression-free survival, performance status, cardiovascular risk factors, breast cancer, cancer immunotherapy safety, ECOG performance status, anticoagulation duration
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4399345686
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms